CCND1 and glioblastoma: Protein levels of cyclin D1 and c-MYC were also significantly reduced by the cotreatment of PP242 and riluzole relative to single agent treatments as shown in Figure 5E. These data demonstrate that cotreatments with PP242 and riluzole result in enhanced levels of G1 arrest and apoptosis in GBM cells.